Stocktoria
Vir Biotechnology, Inc. VIR
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-10-11
Vir Biotechnology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 16,434,122 | $146.3M | 11.78% |
| CITADEL ADVISORS LLC | 2,203,876 | $19.7M | 1.58% |
| Point72 Asset Management, L.P. | 1,952,234 | $17.5M | 1.4% |
| TWO SIGMA INVESTMENTS, LP | 1,439,494 | $12.9M | 1.03% |
| D. E. Shaw & Co., Inc. | 817,685 | $7.3M | 0.59% |
| RENAISSANCE TECHNOLOGIES LLC | 761,364 | $6.8M | 0.55% |
| AQR CAPITAL MANAGEMENT LLC | 566,009 | $5.1M | 0.41% |
| MILLENNIUM MANAGEMENT LLC | 489,360 | $4.4M | 0.35% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.